Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 2003 Sep;60(9):676–679. doi: 10.1136/oem.60.9.676

Lymphohaematopoeitic cancer mortality among workers with benzene exposure

J Collins 1, B Ireland 1, C Buckley 1, D Shepperly 1
PMCID: PMC1740628  PMID: 12937190

Abstract

Lymphohaematopoeitic cancer mortality was examined among 4417 workers at a chemical plant by cumulative and peak benzene exposure. There was little evidence of increasing risk with increasing cumulative exposure for all leukaemias or acute non-lymphocytic leukaemias (ANL), or the other lymphohaematopoeitic cancers with the exception of multiple myeloma. For multiple myeloma, the SMRs were 1.1 (95% CI 0.3 to 2.5) in the non-exposed group, 1.4 (95% CI 0.2 to 5.1) in the <1 ppm-years, 1.5 (95% CI 0.2 to 5.4) in the 1–6 ppm-years, and 2.6 (95% CI 0.7 to 6.7) in the >6 ppm-years group. We found no trends by peak exposures for any of the cancers. However, when peak exposures over 100 ppm for 40 or more days were considered, the observed number of all leukaemias (SMR = 2.7, 95% CI 0.8 to 6.4), ANL (SMR = 4.1, 95% CI 0.5 to 14.9), and multiple myeloma (SMR = 4.0, 95% CI 0.8 to 11.7) were greater than expected. While the observed number of deaths is small in this study, the number of peak exposures greater than 100 ppm to benzene is a better predictor of risk than cumulative exposure. The dose rate of benzene and a threshold for exposure response may be important factors for evaluating lymphohaematopoietic risk.

Full Text

The Full Text of this article is available as a PDF (83.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksoy M. Different types of malignancies due to occupational exposure to benzene: a review of recent observations in Turkey. Environ Res. 1980 Oct;23(1):181–190. doi: 10.1016/0013-9351(80)90104-8. [DOI] [PubMed] [Google Scholar]
  2. Aksoy M., Erdem S., DinCol G. Leukemia in shoe-workers exposed chronically to benzene. Blood. 1974 Dec;44(6):837–841. [PubMed] [Google Scholar]
  3. Austin H., Cole P. Cigarette smoking and leukemia. J Chronic Dis. 1986;39(6):417–421. doi: 10.1016/0021-9681(86)90108-6. [DOI] [PubMed] [Google Scholar]
  4. Austin H., Delzell E., Cole P. Benzene and leukemia. A review of the literature and a risk assessment. Am J Epidemiol. 1988 Mar;127(3):419–439. doi: 10.1093/oxfordjournals.aje.a114820. [DOI] [PubMed] [Google Scholar]
  5. Bond G. G., McLaren E. A., Baldwin C. L., Cook R. R. An update of mortality among chemical workers exposed to benzene. Br J Ind Med. 1986 Oct;43(10):685–691. doi: 10.1136/oem.43.10.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Decouflé P., Blattner W. A., Blair A. Mortality among chemical workers exposed to benzene and other agents. Environ Res. 1983 Feb;30(1):16–25. doi: 10.1016/0013-9351(83)90161-5. [DOI] [PubMed] [Google Scholar]
  7. Goldstein B. D. Is exposure to benzene a cause of human multiple myeloma? Ann N Y Acad Sci. 1990;609:225–234. doi: 10.1111/j.1749-6632.1990.tb32070.x. [DOI] [PubMed] [Google Scholar]
  8. Hayes R. B., Yin S. N., Dosemeci M., Li G. L., Wacholder S., Travis L. B., Li C. Y., Rothman N., Hoover R. N., Linet M. S. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997 Jul 16;89(14):1065–1071. doi: 10.1093/jnci/89.14.1065. [DOI] [PubMed] [Google Scholar]
  9. Ireland B., Collins J. J., Buckley C. F., Riordan S. G. Cancer mortality among workers with benzene exposure. Epidemiology. 1997 May;8(3):318–320. doi: 10.1097/00001648-199705000-00016. [DOI] [PubMed] [Google Scholar]
  10. Irons R. D., Heck H., Moore B. J., Muirhead K. A. Effects of short-term benzene administration on bone marrow cell cycle kinetics in the rat. Toxicol Appl Pharmacol. 1979 Dec;51(3):399–409. doi: 10.1016/0041-008x(79)90364-8. [DOI] [PubMed] [Google Scholar]
  11. Landrigan P. J. Benzene and blood: one hundred years of evidence. Am J Ind Med. 1996 Mar;29(3):225–226. doi: 10.1002/(SICI)1097-0274(199603)29:3<225::AID-AJIM1>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  12. Ott M. G., Townsend J. C., Fishbeck W. A., Langner R. A. Mortality among individuals occupationally exposed to benzene. Arch Environ Health. 1978 Jan-Feb;33(1):3–10. doi: 10.1080/00039896.1978.10667299. [DOI] [PubMed] [Google Scholar]
  13. Paxton M. B., Chinchilli V. M., Brett S. M., Rodricks J. V. Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution. Risk Anal. 1994 Apr;14(2):147–154. doi: 10.1111/j.1539-6924.1994.tb00039.x. [DOI] [PubMed] [Google Scholar]
  14. Rinsky R. A., Smith A. B., Hornung R., Filloon T. G., Young R. J., Okun A. H., Landrigan P. J. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med. 1987 Apr 23;316(17):1044–1050. doi: 10.1056/NEJM198704233161702. [DOI] [PubMed] [Google Scholar]
  15. Rinsky R. A., Young R. J., Smith A. B. Leukemia in benzene workers. Am J Ind Med. 1981;2(3):217–245. doi: 10.1002/ajim.4700020305. [DOI] [PubMed] [Google Scholar]
  16. Rushton L., Romaniuk H. A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med. 1997 Mar;54(3):152–166. doi: 10.1136/oem.54.3.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schnatter A. R., Armstrong T. W., Nicolich M. J., Thompson F. S., Katz A. M., Huebner W. W., Pearlman E. D. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med. 1996 Nov;53(11):773–781. doi: 10.1136/oem.53.11.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schnatter A. R., Nicolich M. J., Bird M. G. Determination of leukemogenic benzene exposure concentrations: refined analyses of the Pliofilm cohort. Risk Anal. 1996 Dec;16(6):833–840. doi: 10.1111/j.1539-6924.1996.tb00834.x. [DOI] [PubMed] [Google Scholar]
  19. Swaen G. M., Meijers J. M. Risk assessment of leukaemia and occupational exposure to benzene. Br J Ind Med. 1989 Dec;46(12):826–830. doi: 10.1136/oem.46.12.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tsai S. P., Wen C. P., Weiss N. S., Wong O., McClellan W. A., Gibson R. L. Retrospective mortality and medical surveillance studies of workers in benzene areas of refineries. J Occup Med. 1983 Sep;25(9):685–692. doi: 10.1097/00043764-198309000-00018. [DOI] [PubMed] [Google Scholar]
  21. Vigliani E. C., Forni A. Benzene and leukemia. Environ Res. 1976 Feb;11(1):122–127. doi: 10.1016/0013-9351(76)90115-8. [DOI] [PubMed] [Google Scholar]
  22. Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses. Br J Ind Med. 1987 Jun;44(6):382–395. doi: 10.1136/oem.44.6.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wong O. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. Occup Environ Med. 1995 Jun;52(6):380–384. doi: 10.1136/oem.52.6.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wong O., Trent L., Harris F. Nested case-control study of leukaemia, multiple myeloma, and kidney cancer in a cohort of petroleum workers exposed to gasoline. Occup Environ Med. 1999 Apr;56(4):217–221. doi: 10.1136/oem.56.4.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yin S. N., Hayes R. B., Linet M. S., Li G. L., Dosemeci M., Travis L. B., Li C. Y., Zhang Z. N., Li D. G., Chow W. H. A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med. 1996 Mar;29(3):227–235. doi: 10.1002/(SICI)1097-0274(199603)29:3<227::AID-AJIM2>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES